Found 6 matching trials
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
PHASE2This clinical trial is designed to evaluate the effectiveness and collect a...
Location
University of California-San Francisco
Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
N/AThe purpose of this sub-study is to provide expanded access of AZEDRA (Ultr...
Status
Approved For Marketing
Location
University of Iowa
Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
PHASE1The purpose of this study is to determine whether iobenguane I 131 is safe ...
Location
New York Presbyterian Hospital-Weill Cornell Medical Center
N2007-01: Ultratrace⢠Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma
PHASE2RATIONALE: Radioactive drugs, such as iodine I 131 metaiodobenzylguanidine ...
Location
Childrens Hospital Los Angeles
Efficacy and Safety of Ultratrace⢠Iobenguane I 131 in Neuroblastoma
PHASE2This is a multi-center, single arm trial of two doses of 18 mCi/kg of Ultra...
Location
Children's Hospital of LA
ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid
PHASE1The purpose of this study is to test the safety of a drug called Ultratrace...
Location
Multiple Locations